On Monday, Mike Doustdar, CEO of Novo, presented an updated strategy in connection with the company's capital markets day in London. Since then, the pharmaceutical giant's stock has fallen by around ten percent. Photo: Angelina Katsanis/Reuters
Novo shares fall 10.4 percent this week after new strategy disappoints investors
Investors continued selling Novo shares Wednesday, extending a decline that began after the Danish pharmaceutical company presented its updated plans for the coming years.
The share price fell 2.5 percent on Wednesday, marking its third consecutive trading day of losses. Novo shares have now...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?